Trypsinogen was identified in cerebrospinal fluid (CSF), where it has not p
reviously been reported and its activation state in experimental subarachno
id haemorrhage (SAH) in rats and in neurosurgical patients was determined.
Trypsinogen activation peptide (TAP) release provided an equimolar marker f
or trypsinogen. Total TAP was significantly reduced to 26% of the baseline
level (P < 0.02) following experimental SAH in 15 rats but not in ten sham
operated controls (P = 0.3). TAP was also measured in patients with rupture
d (n = 11) and unruptured (n = 9) aneurysms who underwent craniotomy to cli
p an aneurysm. Postoperatively there was a significant fall in TAP concentr
ation (P < 0.005) in both groups. Trypsinogen, as identified by CSF levels
of TAP, is activated by SAH in rats and by craniotomy for aneurysmal clippi
ng in patients. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.